BioSpace News Archive

AIVITA Biomedical, Inc., a private biotechnology company developing personalized vaccines for the treatment of cancer and prevention of COVID-19, has closed its Series B-2 financing round for up to $25 million . Financing was provided by several life sciences investment firms. Proceeds will support clinical development of AIVI

Medifast, Inc . (NYSE: MED), the global company behind one of the fastest-growing health and wellness communities, OPTAVIA®, announced today that Dan Chard , Chairman and Chief Executive Officer, and Jim Maloney , Chief Financial Officer, will present at the 23rd Annual ICR Conference on Monday, January 11, 2021 virtually.

U.S. Renal Care (USRC), a leading provider of dialysis services caring for more than 26,000 individuals living with kidney disease, announced it will obtain and distribute the monoclonal antibody therapy, Bamlan

Recent peer-reviewed publications continue to demonstrate the clinical advantage of ViviGen’s lineage-committed, viable bone cells in high-risk foot and ankle procedures

CVS Health Corporation (NYSE: CVS) today announced that President and Chief Executive Officer Larry Merlo, Executive Vice President and Chief Financial Officer Eva Boratto, and Executive Vice President and President, Aetna Karen Lynch, will participate in a fireside chat with investors at the J.P. Morgan 39th Annual Healthcare Conference

Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has acknowledged receipt of the company’s New Drug Application (NDA) resubmission for ALKS 3831 (olanzapine/samidorphan) for the treatment of adults with schizophr

Invitae Corporation (NYSE: NVTA), a leading medical genetics company, today announced that Sean George , co-founder and chief executive officer of Invitae, will present at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 10:50 a.m. Eastern/ 7:50 a.m. Pacific. Following the company presenta